Ledger.Open graph →
SEC Form D · filed April 25, 2017

Cancer Prevention Pharmaceuticals, Inc

Offering
$3.0M
Sold
$700K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TUCSON, AZ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Christopher Richied · Tucson, AZExecJon Saxe · Tucson, AZDirectorEugene Gerner, Ph.D · Tucson, AZDirectorJeffrey Jacob · Tucson, AZExec · DirectorRichard Love · Tucson, AZDirectorDaniel Donovan · Tucson, AZDirectorSean Schaeffer · RENO, NVDirectorSteven Rosenthal · RENO, NVDirectorMirza Rahimani · VANCOUVER, British Columbia, CanadaExecMoe Dilon · VANCOUVER, British Columbia, CanadaDirectorEdward L. Boyd · PETALUMA, CADirectorJerry Grafstein · VANCOUVER, British Columbia, CanadaExec · DirectorSandra Buschau · VANCOUVER, British Columbia, CanadaDirectorJoseph Hackett · York, PAExecJoseph Jacobson · BOSTON, MAExec · DirectorJeremy Wertheimer · BOSTON, MADirectorOded Kadosh · BOSTON, MADirectorJonathan M. Wainwright · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗